Chinese cancer therapy study retracted

A retracted study initially claimed that administering immunotherapy in the morning significantly extended survival and delayed tumor progression in lung cancer patients. The research, conducted in China and published in Nature Medicine, was later withdrawn due to inconsistencies, data alterations, and irregularities in trial execution. The controversy highlighted concerns about research integrity and China's growing role in biomedical research.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل